RE:RE:RE:RE:RE:RE:RE:RE:2022 reimbursement rates do more dd, you dope....
Quipt will have the opportunity to acquire used equipment and repair in-house, allowing Quipt the ability to redeploy equipment on its patient population, thus providing the opportunity to lower equipment acquisition costs.
Carlito3311 wrote: The guidance didn't have to factor in the cost side of supplies because there was no earnings guidance. Adjusted ebidta is closer to a revenue figure than an earnings figure. Equipment costs and associated D&A fall below the Adj. EBITDA line so are unaffected...but it effects the real economics and cash flow. FCF - even at $40 million of Adj EBITDA is still likely only $5-8 million after deducting $20-25 million of capex/lease payments, and another $10 million for rent expense and working capital investments.